Active Pharmaceutical Ingredient (API)
Empagliflozin
SGLT2 Inhibitor (Antidiabetic/Cardioprotective)
Another highly effective SGLT2 inhibitor used for Type 2 Diabetes and reducing the risk of cardiovascular death and hospitalization for heart failure. Its mechanism involves reducing glucose reabsorption in the kidney. Empagliflozin has demonstrated compelling evidence for its cardiorenal protective effects.
Technical Profile
- Reference Code
- EMP122
- CAS Number
- 864070-44-0
- Molecular Weight
- 450.91 g/mol
- Chemical Class
- N/A
- Molecular Formula
- C23H27ClO7
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Empagliflozin as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||